Why is Godavari Drugs falling/rising?

As of 07-Jul, Godavari Drugs Ltd is experiencing a decline in its stock price, currently at Rs 90.00, reflecting a decrease of Rs 1.0 or 1.1%. Today's price summary indicates that the stock underperformed its sector by 1.02%, opened with a loss of 2.03%, and reached an intraday low of Rs 89.15. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 12.03% compared to the 5-day average. Over the past year, the stock has generated a return of -13.25%, while profits have decreased by 22.1%, contributing to its negative performance. In the broader market context, Godavari Drugs' short-term performance has been significantly worse than the benchmark, with a 1-week return of -3.27% compared to the Sensex's -0.20%. This underperformance is compounded by weak long-term fundamentals, including a high Debt to EBITDA ratio of 3.15 times and a CAGR growth in operating profits of only 13.98% over the last five years. The company's negative results, including a 42.84% decline in PAT and a 33.10% drop in net sales over the past nine months, further exacerbate the situation, leading to a perception of weak financial health among investors.